Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug
- PMID: 31252189
- DOI: 10.1016/j.cgh.2019.06.032
Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug
Comment on
-
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.Clin Gastroenterol Hepatol. 2019 Dec;17(13):2776-2784.e4. doi: 10.1016/j.cgh.2019.04.061. Epub 2019 May 9. Clin Gastroenterol Hepatol. 2019. PMID: 31077838 Free PMC article.